Medical Alley, MN – The Medical Alley Association is pleased to welcome Bayer G4A as its newest sustaining member.
“We are excited to become a sustaining member and partner with Medical Alley to accelerate partnerships towards our vision Health For All through digital health, in order to sustainably scale digital health for people when and where it matters most,” said Dominick Kennerson, Global Head of Bayer G4A, Bayer’s digital health and partnerships arm. “With our partnership, we are looking forward to fulfilling our joint ambitions to support and scale digital health companies and innovators across the U.S.,” said Sophie Park, leading the Strategic Investment and Partnerships, at Bayer G4A. G4A will also be based in the U.S. beginning in February 2022 to further build and strengthen the relationships with healthcare innovators across regions.
Bayer G4A is the digital health partnerships and investments team at Bayer working together with digital health companies, investors, government, academia, and strategic partners. G4A engages with their partners at various stages to successfully implement programs and resources which create strong alliances across digital health.
“On behalf of Medical Alley, we are pleased to welcome Bayer G4A as a sustaining member of our innovative community,” said Roberta Dressen, President and CEO of the association. “Bayer G4A’s engagement at this level will support our thriving ecosystem that includes our legacy industry leaders as well as the vibrant startups that serve as a magnet to this region on the global forefront of health innovation and care.”
G4A is Bayer’s digital health partnerships and investments team dedicated to scaling digital health companies in order to create impact and change the experience of health. The team’s vision is to ensure health for all through digital health. To attain this goal, G4A works together with like-minded start-ups, digital health companies, government, investors, and strategic partners to offer early stage start-up investments as well as commercial partnerships and late stage investments. As Europe’s first biopharmaceutical accelerator and since 2013, Bayer G4A has supported over 150 digital health companies, resulting in more than 35 direct collaborations. https://g4a.health
Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Its products and services are designed to help people and planet thrive by supporting efforts to master the major challenges presented by a growing and aging global population. Bayer is committed to drive sustainable development and generate a positive impact with its businesses. At the same time, the Group aims to increase its earning power and create value through innovation and growth. The Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2020, the Group employed around 100,000 people and had sales of 41.4 billion euros. R&D expenses before special items amounted to 4.9 billion euros. For more information, go to www.bayer.com.
Founded in 1984, MAA supports and advances the global leadership of Medical Alley’s healthcare industry and its connectivity around the world. MAA delivers the collective influence, intelligence, and interactions that support Medical Alley.